<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR132">
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Westby</surname>
    <given-names>M</given-names>
   </name>
   <name>
    <surname>Smith-Burchnell</surname>
    <given-names>C</given-names>
   </name>
   <name>
    <surname>Mori</surname>
    <given-names>J</given-names>
   </name>
   <name>
    <surname>Lewis</surname>
    <given-names>M</given-names>
   </name>
   <name>
    <surname>Mosley</surname>
    <given-names>M</given-names>
   </name>
   <name>
    <surname>Stockdale</surname>
    <given-names>M</given-names>
   </name>
   <name>
    <surname>Dorr</surname>
    <given-names>P</given-names>
   </name>
   <name>
    <surname>Ciaramella</surname>
    <given-names>G</given-names>
   </name>
   <name>
    <surname>Perros</surname>
    <given-names>M</given-names>
   </name>
  </person-group>
  <article-title>Reduced maximal inhibition in phenotypic susceptibility assays indicates that viral strains resistant to the CCR5 antagonist maraviroc utilize inhibitor-bound receptor for entry</article-title>
  <source>J Virol</source>
  <year>2007</year>
  <volume>81</volume>
  <issue>5</issue>
  <fpage>2359</fpage>
  <lpage>2371</lpage>
  <pub-id pub-id-type="doi">10.1128/JVI.02006-06</pub-id>
  <?supplied-pmid 17182681?>
  <pub-id pub-id-type="pmid">17182681</pub-id>
 </element-citation>
</ref>
